TNF has a complex, and presumably multifaceted, role in the immunopathogenesis of MS, as suggested by both animal experiments and clinical studies in humans, including the failure of an anti-TNF clinical trial [15,16,17]. The gene discussed is TNF; the disease is myeloid sarcoma.